Merus (NASDAQ: MRUS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Merus (NASDAQ: MRUS) through any online brokerage.
There are no as such competitors for Merus.
The latest price target for Merus (NASDAQ: MRUS) was reported by Stifel on Tuesday, August 2, 2022. The analyst firm set a price target for 38.00 expecting MRUS to rise to within 12 months (a possible 51.24% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Merus (NASDAQ: MRUS) is $25.125 last updated Today at August 9, 2022, 3:51 PM UTC.
There are no upcoming dividends for Merus.
Merus’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Merus.
Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.